Cost‐effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy‐resistant depression at secondary mental health care settings-Reference-Cited by-同舟云学术

Cost‐effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy‐resistant depression at secondary mental health care settings

Published:2021-09-17 Issue:11 Volume:75 Page:341-350
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin. Neurosci.

Author:

Sado Mitsuhiro¹²^ORCID,Koreki Akihiro¹²³,Ninomiya Akira¹²,Kurata Chika¹,Mitsuda Dai¹,Sato Yasunori⁴⁵,Kikuchi Toshiaki¹,Fujisawa Daisuke¹,Ono Yutaka⁶,Mimura Masaru¹²^ORCID,Nakagawa Atsuo¹⁴^ORCID

Affiliation:

1. Department of Neuropsychiatry Keio University School of Medicine Tokyo Japan

2. Center for Stress Research Keio University Tokyo Japan

3. Department of Psychiatry National Hospital Organization Shimofusa Psychiatric Medical Center Chiba Japan

4. Clinical and Translational Research Center Keio University Hospital Tokyo Japan

5. Department of Preventive Medicine and Public Health Keio University School of Medicine Tokyo Japan

6. Ono Institute for Cognitive Behavior Therapy Tokyo Japan

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology,Neurology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13298

Reference48 articles.

1. Treatment resistant depression: methodological overview and operational criteria

2. Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression

3. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

4. Choosing indicators for the health-related SDG targets

5. The Economic Burden of Depression in the United States

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Cost-Utility Analysis of Screening and Cognitive Behavioral Therapy compared to usual care for Perinatal Depression;2024-08-10

2. CBT may be cost effective in certain patients for pharmacotherapy-resistant depression in Japan;PharmacoEconomics & Outcomes News;2021-09